Lexicon Pharmaceuticals (LXRX)

• Market cap: $1.04B
• 1 day: 0.86%
• 5 days: 1.74%
• 1 month: -2.5%
• 3 months: 45.34%
• 6 months: 101.72%
• Year to date: 105.26%
• 1 year: 129.41%
• 5 years: -33.9%
• 10 years: -86%
• Sector: Healthcare
• Industry: Biotechnology

About: Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, and LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Employees: 81